Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease von MORRIS, J. C, CYRUS, P. A, ORAZEM, J, MAS, J, BIEBER, F, RUZICKA, B. B, GULANSKI, B

Volltext

Metrifonate treatment of the cognitive deficits of Alzheimer's disease von CUMMINGS, J. L, CYRUS, P. A, BIEBER, F, MAS, J, ORAZEM, J, GULANSKI, B

Volltext

Metrifonate treatment of AD : Influence of APOE genotype von FARLOW, M. R, CYRUS, P. A, NADEL, A, LAHIRI, D. K, BRASHEAR, A, GULANSKI, B

Volltext

Metrifonate Therapy in Alzheimer’s Disease: A Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials von Farlow, M.R., Cyrus, P.A.

Volltext

Metrifonate Enhances the Ability of Alzheimer's Disease Patients to Initiate, Organize, and Execute Instrumental and Basic Activities of Daily Living von Gélinas, Isabelle, Gauthier, Serge, Cyrus, PamelaA

Volltext

Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia von Boel, Judith A., Bie, Rob M.A., Schmand, Ben A., Dalrymple‐Alford, John C., Marras, Connie, Adler, Charles H., Goldman, Jennifer G., Tröster, Alexander I., Burn, David J., Litvan, Irene, Geurtsen, Gert J., Bernard, Bryan, Stebbins, Glenn, Filoteo, J. Vincent, Weintraub, Daniel, Caviness, John N., Belden, Christine, Zabetian, Cyrus P., Cholerton, Brenna A., Huang, Xuemei, Eslinger, Paul J., Leverenz, James B., Duff‐Canning, Sarah, Farrer, Matt, Anderson, Tim J., Myall, Daniel J., Naismith, Sharon L., Lewis, Simon J.G., Halliday, Glenda M., Wu, Ruey‐Meei, Williams‐Gray, Caroline H., Breen, David P., Barker, Roger A., Yarnall, Alison J., Klein, Martin, Mollenhauer, Brit, Trenkwalder, Claudia, Kulisevsky, Jaime, Pagonabarraga, Javier, Gasca‐Salas, Carmen, Rodriguez‐Oroz, Maria C., Junque, Carme, Segura, Barbara, Barone, Paolo, Santangelo, Gabriella, Cammisuli, Davide M., Biundo, Roberta, Antonini, Angelo, Weis, Luca, Pedersen, Kenn Freddy, Alves, Guido

Volltext

Efficacy of Metrifonate in Improving the Psychiatric and Behavioral Disturbances of Patients with Alzheimer's Disease von Cummings, Jeffrey L., Nadel, A., Masterman, Donna, Cyrus, Pam A.

Volltext

Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease von BLASS, J. P, CYRUS, P. A, BIEBER, F, GULANSKI, B

Volltext

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, plac... von Jann, Michael W., Cyrus, Pamela A., Eisner, Larry S., Margolin, David L, Griffin, Traci, Gulanski, Barbara

Volltext

Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate... von Blass, J P, Cyrus, P A, Bieber, F, Gulanski, B

Volltext

Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group von Cummings, J L, Cyrus, P A, Bieber, F, Mas, J, Orazem, J, Gulanski, B

Volltext

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, plac... von Jann, M W, Cyrus, P A, Eisner, L S, Margolin, D I, Griffin, T, Gulanski, B

Volltext

Adaptive Designs for Clinical Trials von Bhatt, Deepak L, Mehta, Cyrus

Volltext

Placebo effects in cognitive training von Foroughi, Cyrus K., Monfort, Samuel S., Paczynski, Martin, McKnight, Patrick E., Greenwood, P. M.

Volltext

Perovskite Ferroelectric Nanoplates Induced a Highly Oriented Growth of P (VDF-TrFE) Films von LIU, Jin, MAI, Jiang-Quan, LI, Shi, REN, Zhao-Hui, LI, Ming, WU, Meng-Jiao, WU, Yong-Jun, LU, Xin-Hui, LI, Xiang, TIAN, He, WANG, Zong-Rong, HAN, Gao-Rong

Volltext

New windows into the brain: Central nervous system-derived extracellular vesicles in blood von Shi, Min, Sheng, Lifu, Stewart, Tessandra, Zabetian, Cyrus P, Zhang, Jing

Volltext

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome von Hill‐Burns, Erin M., Debelius, Justine W., Morton, James T., Wissemann, William T., Lewis, Matthew R., Wallen, Zachary D., Peddada, Shyamal D., Factor, Stewart A., Molho, Eric, Zabetian, Cyrus P., Knight, Rob, Payami, Haydeh

Volltext

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region von Wissemann, William T., Hill-Burns, Erin M., Zabetian, Cyrus P., Factor, Stewart A., Patsopoulos, Nikolaos, Hoglund, Bryan, Holcomb, Cherie, Donahue, Ryan J., Thomson, Glenys, Erlich, Henry, Payami, Haydeh

Volltext

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases von Espay, Alberto J, Vizcarra, Joaquin A, Marsili, Luca, Lang, Anthony E, Simon, David K, Merola, Aristide, Josephs, Keith A, Fasano, Alfonso, Morgante, Francesca, Savica, Rodolfo, Greenamyre, J Timothy, Cambi, Franca, Yamasaki, Tritia R, Tanner, Caroline M, Gan-Or, Ziv, Litvan, Irene, Mata, Ignacio F, Zabetian, Cyrus P, Brundin, Patrik, Fernandez, Hubert H, Standaert, David G, Kauffman, Marcelo A, Schwarzschild, Michael A, Sardi, S Pablo, Sherer, Todd, Perry, George, Leverenz, James B

Volltext

Fragility fractures in Europe: burden, management and opportunities von Borgström, Fredrik, Karlsson, Linda, Ortsäter, Gustav, Norton, Nicolas, Halbout, Philippe, Cooper, Cyrus, Lorentzon, Mattias, McCloskey, Eugene V., Harvey, Nicholas C., Javaid, Muhamamd K., Kanis, John A.

Volltext